We are delighted to congratulate Kirit Singh on the acceptance of his late-breaking abstract for oral presentation at the 21st Meeting of the European Association of Neuro-Oncology (EANO 2026), taking place in Rome, Italy, from September 24–27, 2026.
His abstract, “A Randomized Surgical Window-of-Opportunity Study Evaluating Fluoxetine and Temozolomide in Recurrent High-Grade Glioma”, was selected for OS06 – Selected Abstracts and EANO-SNO Scholarships on Friday, September 25, 2026.
We also congratulate Anna Corcoran, who will present a poster on “A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in Recurrent Glioblastoma: The MOAB Trial” (Control No. 266), and Julia Louw, for her abstract “What Drives Long-Term Survival in Glioblastoma? A Multi-Omic Analysis of Distinct Survival Phenotypes”.
Congratulations to all presenters and collaborators on this important recognition.